Lidocaine
Check on isomerdesign
Lidocaine
Check on pubchem
Lidocaïne
Check on druglab
Lidocaine
Check on drugmap
Data
InChI: InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)
Synonyms: Xylocaine (TN),Xyloneural (free base),BSPBio_001359,NCGC00015611-18, Diethylaminoaceto-2,6-xylidide,LIDOCAINE [JAN], Lidocaine (VAN), Xilina,ZTlido,Lidocaine Base,Lidocain, Alpha-Diethylamino-2,6-dimethylacetanilide, Lidocaine Monohydrochloride,HMS2089E15,Leostesin, Xylocard,LIDOCAINE COMPONENT OF SYNERA,Dentipatch,KBio3_002224,NCGC00015611-16,Lidocaine, European Pharmacopoeia (EP) Reference Standard,SY052029,KBio3_000157,NCGC00015611-31,Lidocaton,Lidoderm,HMS1791D21, N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide,ALGRX 3268,CCG-100824, Lanabiotic, Norwood Sunburn Spray,FORTACIN COMPONENT LIDOCAINE,DTXCID9025166,Diethylaminoacet-2,6-xylidide,2-(Diethylamino)-2',6'-acetoxylidide,Esracaine,Maricaine,Lidocaine,Lignocaine,BRD-K52662033-003-05-5, Xylocaine Endotracheal,AMY25560,Maybridge1_002571,KBio2_005215,.alpha.-Diethylaminoaceto-2,6-xylidide,DSSTox_GSID_45166,NCGC00022176-05,BDBM50017662,Xyloneural (Salt/Mix), Xycaine,ELA-Max,Solcain, Alpha-(Diethylamino)-2,6-acetoxylidide,BRN 2215784,Spectrum4_000070,Lida-Mantle, Xylocaine-Mpf with Glucose,Lignocainum,NCGC00015611-09, Xylocaine Viscous, Rocephin Kit, LQZ,NSC-789222,Xylocain,UNII-98PI200987, EMBOLEX,alpha-Diethylamino-2,6-dimethylacetanilide,Lidocaine (Alphacaine),SCHEMBL15689, L-Caine,Lidocaine, analytical standard,alfa-Dietilamino-2,6-dimetilacetanilide [Italian], After Burn Gel,IDI1_033829,ZINC20237,Neosporin Plus (Salt/Mix), Zilactin-L,NCGC00015611-05, Isicaine, Lidocaina,.alpha.-Diethylamino-2,6-dimethylacetanilide,CDS1_000283,2', 2-(diethylamino)-,KBio2_001598, Dentipatch,C07073,Bio2_000559,N-(2,6-Dimethylphenyl)-N2,N2-diethylglycinamide, Lida-Mantle, Rucaina,IDI1_000174,Lidocainum,Lidocaine (JP17/USP/INN),NCGC00022176-06,2-(Diethylamino)-N-(2,6-Dimethylphenyl)ethanamide, Xilocaina [Italian],Cito optadren,HMS1989D21,DTXSID1045166,Lidocaina,SYNERA COMPONENT LIDOCAINE, Lidocaton,MLS001074177,LIDOCAINE COMPONENT OF EMLA,BCP09081,EMLA COMPONENT LIDOCAINE,Prestwick3_000050,AC-10282,NCGC00022176-07,NCGC00015611-13,BPBio1_000197,NCGC00015611-04, Lidocaine Hydrocarbonate,98PI200987, Xylocaine,Tox21_110183_1,LIDOCAINE [WHO-IP],AB00053581-27,A833036,2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide, DermaFlex,DSSTox_RID_80716,NCGC00015611-12,L-Caine, Xylocitin,Spectrum5_001549,Dalcaine,SCHEMBL17967359,Tox21_110183, Lidocaine (JP15/USP/INN),Versatis,AB00053581-28,WLN: 2N2 & 1VMR B1 F1,NCGC00015611-14,4-12-00-02538 (Beilstein Handbook Reference),M06299,NCGC00015611-01,LIDOPEN,Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-,AB00053581_29,Bio1_000379,NCGC00015611-10,ROCEPHIN KIT COMPONENT LIDOCAINE,KBioSS_000079,NCGC00015611-11,NC00074, Lidocaine [USAN:INN:JAN],N1-(2,6-dimethylphenyl)-2-(diethylamino)acetamide,NSC789222, L1026_SIGMA,Q216935,Bio2_000079,CHEMBL79,Lidocaine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide, Solcain,Lidocaine, powder, After Burn Double Strength Spray,BSPBio_003004,NCGC00015611-03,HMS3393C21,Lidothesin (Salt/Mix),2-(Diethylamino)-N-(2,6-dimethylphenyl)-acetamide,Lopac0_000669,MLS001423964,STK552033, Xylocaine CO2,Epitope ID:116205, ELA-Max,HMS2235O14, Dentipatch (TN), Dilocaine,KBioGR_000079, Lidocaine Carbonate,Lidaform HC (Salt/Mix),LIDOCAINE [MART.],Bio1_000868,Lidamantle HC (Salt/Mix),LIDOCAINE [USP-RS], Remicaine,HMS2051C21,Prestwick1_000050,Jetocaine,NCGC00022176-08,HMS3428O07,ORAQIX COMPONENT LIDOCAINE,Lignocaine base,SMR000058189,Duncaine,Anestacon,KBioSS_001598,Z55135799, Lidoject-2,Cappicaine,2',6'-Acetoxylidide, 2-(diethylamino)-,EINECS 205-302-8,NCGC00015611-07, Lignocainum,2-(Diethylamino)-2'',6''-acetoxylidide, Lignocaine,BSPBio_000179,LANABIOTIC COMPONENT LIDOCAINE,NCGC00022176-09,SPBio_002100,Lidocaine [USP:INN:BAN:JAN],KBioGR_000599,Bio1_001357,KBio2_004166,LIDOCAINE COMPONENT OF ROCEPHIN KIT,LIDOCAINE [USP MONOGRAPH],Lidocaine 1.0 mg/ml in Methanol,HMS3651G09,Spectrum2_001343, Cuivasil,NINDS_000174,N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide, Esracaine,L0156,Xilina,Qualigens,CS-2070,Opera_ID_385,.omega.-Diethylamino-2,6-dimethylacetanilide, Anestacon Jelly, Xylestesin,DivK1c_000174,EN300-6472705, Zingo, 2-(Diethylamino)-2',6'-acetoxylidide,91484-71-8,Lidocainum [INN-Latin],NCGC00015611-02,LIDOCAINE [INN], Octocaine-100, Xylotox,Dilocaine,AB00053581, Xylocaine-Mpf,KBio1_000174,A18187,BRD-K52662033-001-02-6, Jetocaine,.alpha.-(Diethylamino)-2,6-acetoxylidide, Xylocaine Dental Ointment, Emla Cream,Gravocain,LIDOCAINE [GREEN BOOK], Octocaine,Isicaina,2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide,LIDOCAINE [WHO-DD],SB19118, Alfa-Dietilamino-2,6-dimetilacetanilide [Italian],SPBio_001525, Xilocaina,NCGC00015611-15, LIDOPEN,MFCD00026733,CAS-73-78-9, Lidocainum, Lidocainum [INN-Latin],NCGC00015611-06, Xylocain,Dentipatch (TN), Xllina,LQZ, 2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide,CHEBI:6456,Lidocaine (VAN),DSSTox_CID_25166,Lidocaine, United States Pharmacopeia (USP) Reference Standard,W-108233,NCGC00015611-08,lidocaine,Xyline, Maricaine,LIDOCAINE [ORANGE BOOK],SW196598-4,HMS3371J04,Xycaine,.alpha.-Diethylamino-2,6-acetoxylidide,Xylocaine, Anestacon,DIETHYLAMINO-2,6-DIMETHYLACETANILIDE,ALGRX-3268,Zingo (Salt/Mix),Remicaine, Leostesin,Lidocaine, British Pharmacopoeia (BP) Reference Standard,AB00053581_30,LIDOCAINE COMPONENT OF LANABIOTIC,EMBOLEX, Xylocaine (TN),LIDOCAIN COMPONENT OF FORTACINE,Isicaine,HMS548M19, CDS1_000283,Cuivasil,MLS000758263, Xylesthesin,Prestwick2_000050, Xylocaine Test Dose,Xilocaina,LIDOCAINE [HSDB],Xylestesin,LIDOCAINE COMPONENT OF ORAQIX, N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide,N1-(2,6-dimethylphenyl)-N2,N2-diethylglycinamide, Xylocaine 5% Spinal,NSC 40030,Lopac-L-5647,KBio3_000158, After Burn Spray,2-diethylamino-2',6'-acetoxylidide, Isicaina, Octocaine-50, Alfa-Dietilamino-2,6-dimetilacetanilide,Rucaina,NSC40030,Xilocaina [Italian],KBio2_000079,N~1~-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide,Xylotox, Lidoject-1, Gravocain, After Burn Double Strength Gel,KBio2_006734,MLS000069724, Duncaine,(2,6-dimethylphenyl)carbamoylmethyl-diethyl-azanium, 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide,Diethylaminoaceto-2,6-xylidide,KBio2_002647, Omega-Diethylamino-2,6-dimethylacetanilide, Cito optadren,Ztilido,DB00281,GTPL2623, Lidocaina [INN-Spanish],Lidocaine, Pharmaceutical Secondary Standard; Certified Reference Material,Spectrum3_001392,D00358,Prestwick0_000050,Lidocaina [INN-Spanish],Xylocitin,LIDOCAINE [EP MONOGRAPH],Xllina, LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE),DivK1c_001323, Lingocaine,LIDOCAINE [VANDF],LIDOCAINE [INCI],AKOS001026768,SDCCGSBI-0050648.P005, Solarcaine aloe extraburn relief cream, 2-Diethylamino-N-(2,6-dimethylphenyl)acetamide,SBI-0050648.P004,LIDOCAINE [MI],2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide hydrate hydrochloride, Xyloneural (free base),s1357,LIDOCAINUM [WHO-IP LATIN],CAS-137-58-6,alfa-Dietilamino-2,6-dimetilacetanilide,Alphacaine,2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide #,NSC-40030, Cappicaine, Alpha-Diethylaminoaceto-2,6-xylidide, Lidoderm,HY-B0185,BRD-K52662033-003-14-7,2-Diethylamino-N-(2,6-dimethylphenyl)acetamide,AS-13718,HSDB 3350,Spectrum_001118, Dalcaine,137-58-6,BIDD:GT0342,LidocaineHClH2O
Estimated data
Solubility: -2.213 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)
Addictivity Prediction: 50.0% (prediction based on www.mdpi.com)
